Myeloma Patients Europe

MPE launches the Myeloma and AL Amyloidosis European Clinical Trial Navigator

23 April 2024 -- Brussels, Belgium -- Myeloma Patients Europe (MPE) has launched today the English version of the Myeloma and AL Amyloidosis European Clinical Trial Navigator, an online search tool to learn about and find clinical trials for myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering multiple myeloma (SMM) and AL amyloidosis in Europe....

Myeloma Patients Europe report finds huge inequalities in access to myeloma clinical trials in Central and Eastern Europe

Brussels, 30 November 2022 - Myeloma Patients Europe (MPE) has launched a first-of-its-kind advocacy report on Addressing access barriers to myeloma clinical trials in Central and Eastern Europe (CEE)
Avenue Louise 143/4, 1050 Brussels Belgium